LBX Pharmacy announced plans to repurchase shares through centralized bidding, with an expected buyback amount of 40 million to 80 million yuan. The maximum repurchase price is set at 18.08 yuan per share, translating to approximately 2.21 million to 4.42 million shares, or 0.29% to 0.58% of total share capital. In the first quarter of 2026, the company reported revenue of 5.481 billion yuan and net profit attributable to the parent of 264 million yuan.
Laobaixing PharmacyCompany announces share buyback of 40-80 million yuan, supporting stock price.
